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Sir,
We read with interest the recent review article by Key (2011),
who concluded that the published results from the epidemio-
logical studies suggest little or no association between the total
intake of fruit and vegetables and the risk of common cancers,
including colorectal, breast and prostate cancer. Although
the association between food intake and cancer is still under
intense debate, we believe that there is a growing body of
clinical evidence suggesting that certain types of food, for example,
those rich in lycopene such as tomatoes, might have beneficial
effects on the development of certain cancers, especially prostate
cancer.
First and foremost, the most recent expert report issued by the
World Cancer Research Fund, together with the American Institute
for Cancer Research, has reviewed the strength of the evidence that
causally correlates food intake to the risk of several forms of
cancer. Basically, it has been concluded that a higher consumption
of several plant foods might protect against cancers of various
sites. In particular, foods rich in folate may protect against
pancreatic cancer, those rich in carotenoids against cancers of the
mouth, pharynx, larynx and lung cancer, those rich in b-carotene
or vitamin C against oesophageal cancer, and those rich in
lycopene against prostate cancer (World Cancer Research Fund/
American Institute for Cancer Research, 2007).
With regard to the lycopene-containing foods, Giovannucci
(1999) carried out a comprehensive review of the epidemiological
data linking tomatoes, tomato-based food products and lycopene
with the risk of cancer. Interestingly, it was found that the relative
risks (RRs) for the comparison between individuals with higher vs
those with lower dietary intakes of tomato-based food products or
between individuals with higher vs those with lower plasma levels
of lycopene were p0.60, respectively, with a stronger evidence for
a potential benefit for prostate cancer. The published data were
also suggestive for potential benefits for lung, oesophagus,
stomach, colorectal, pancreas, breast and cervix cancers, although
a direct cause–effect relationship could not be definitively
assessed (Giovannucci, 1999). A large cross-sectional study was
conducted in 2002, including patients below age 80 years with
incident, histologically confirmed cancer of the oral cavity and
pharynx (n¼754), oesophagus (n¼304), colorectum (n¼1953),
breast (n¼2529), ovary (n¼1031), as well as over 5000 patients
below age 80 years with acute, non-neoplastic, non-hormone-
related diseases. The analysis of the data showed that the
multivariate RR of oral, pharyngeal and oesophageal cancer
decreased across subsequent levels of lycopene intake to reach
0.7 (95% confidence interval (CI) 0.4–1.0) for oral and pharyngeal,
and 0.7 (95% CI 0.4–1.1) for oesophageal cancer in the highest
quintile of intake (La Vecchia, 2002). In the same year,
Giovannucci (2002) further reviewed the published epidemio-
logical studies of tomatoes and prostate cancer, and concluded that
a high tomato or lycopene consumption might provide up to 40%
reduction in the risk of prostate cancer. In a recent meta-analysis
of 21 observational studies, Etminan et al (2004) confirmed that
tomatoes and lycopene-containing foods might have an anti-
prostate cancer activity. Compared with non-frequent users of
tomato products, the RR of prostate cancer among consumers of
high amounts of raw tomato was 0.89 (95% CI 0.80–1.00). For a
high intake of cooked tomato products, the corresponding RR was
0.81 (95% CI 0.71–0.92) (Etminan et al, 2004). More recently, the
putative anti-prostate cancer activity of tomatoes and lycopene-
containing foods was further supported by an experimental study,
in which tomato diet significantly increased overall survival,
delayed progression from prostatic intraepithelial neoplasia to
adenocarcinoma, and decreased the incidence of poorly differen-
tiated carcinoma in a model of transgenic adenocarcinoma of
the mouse prostate (Pannellini et al, 2010). Moreover, in another
experimental study, the investigators produced genetically
modified tomatoes that overexpressed Lc and C1, that is, two
regulatory genes encoding select transcription factors that control
the biosynthesis of anthocyanins in mice. In such study, cancer-
susceptible Trp 53 /  mice, which were supplemented with these
genetically modified tomatoes rich in anthocyanins, showed a
significant extension of their life span (Butelli et al, 2008). The
outcome of this study is noteworthy, in that it paves the way to
further research aimed at establishing whether lycopene, in
combination with existing therapies, might be used as a natural
compound for prevention and treatment of human cancer.
Although a clear cause–effect relationship between tomato
products, lycopene and cancer risk has not yet been established,
and further research is urgently needed to draw a definitive
conclusion, we believe that the accumulated literature suggests
the possibility that a higher consumption of tomato products
or lycopene is safe and may have potential benefits for lowering
the risk of cancer as well as of other severe pathologies
(e.g., atherosclerosis). Published online 22 February 2011
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